Observational Study of TissuePatch SF in Prevention of Air Leaks Following Lung Resection

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorC. R. Bard

About this trial

Post-market, observational study to assess effectiveness of TissuePatch SF in managing/preventing air leaks after lung resection.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Is ≥18 and <80 years of age

Undergoing planned (not emergent) video-assisted thoracic surgery pulmonary resection

Understands and is willing to comply with all study related procedures

Has provided signed informed consent

Disqualifiers

Women who are pregnant or lactating or, if of childbearing potential, are unwilling to use birth control for 6-months following surgery

Has severe congestive heart failure, pulmonary or renal failure, serious haematological disorder or significant liver disease

Has previously undergone a pneumonectomy

Has a bronchial fistula

Trial population

Patients undergoing lung resection

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • TissuePatch Sealant Film

    Device

    Sealant film

Treatment groups

250 Participants
are divided into 1 treatment group
Group A: Patients with intra-operative air leak detected during lung resection1 intervention

Trial outcomes

Primary outcomes

1

Intra-operative air leaks

Air leaks successfully sealed or reduced as assessed by a submersion air leak test

Time frame
Prior to the completion of surgery

Secondary outcomes

1

Overall device safety

Incidence of serious adverse events

Time frame
3-months post surgery
2

Overall device safety

Adverse events probably or causally related to the study device

Time frame
6-months post-surgery

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: